Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
CDC via AP
Some populations in East Africa have developed partial immunity to the deadliest form of malaria, a new study finds. In some cases, genetic changes reduced the risk of malaria by up to 40 percent.
What it means: The gene variant in certain people of East African descent helps keep a parasite that causes malaria from entering the bloodstream. The new findings could accelerate research into ways to combat malaria, as they're a next step toward discovering protective aspects from gene mutations or variants.
How they did it: Researchers sequenced the genomes of 765 people from 10 ethnic groups in Gambia, Burkina Faso, Cameroon and Tanzania and analyzed thousands of genomes from an existing database of people from across the continent. They then compared both against genomes from severe cases of malaria and found a variation called DUP4 that lowered the risk of malaria was present almost exclusively in people of East Africa descent. They found no DUP4, for instance, in the 4,791 Gambian individuals in the study.
Next steps: DUP4 is not widespread in Africa. Scientists need to determine why these East African sub-populations developed the gene variant. Is it a recent development? Did it emerge to combat a particular strain of malaria only found in East Africa? Because malaria parasites invade through membranes and replicate in red blood cells, scientists also want to study how DUP4 keeps the parasites out.
Be smart: The parasite this gene variant protects against is called Plasmodium falciparum. It's transmitted to humans by female Anopheles mosquitoes. Malaria from this combination of mosquito and parasite is extremely deadly; it has the highest complication rates and mortality and is one of the major causes of childhood mortality from malaria in Africa.